Y. Sakurai

发表

Mutant botrocetin‐2 inhibits von Willebrand factor‐induced platelet agglutination

M. Matsumoto, Y. Fujimura, J. Hamako, 2017, Journal of thrombosis and haemostasis : JTH.

Identification and recombinant analysis of botrocetin-2, a snake venom cofactor for von Willebrand factor-induced platelet agglutination.

Y. Ozeki, T. Kokubo, S. Kawsar, 2012, Biochemistry.

Total inhibition of high shear stress induced platelet aggregation by homodimeric von Willebrand factor A1‐loop fragments

K. Titani, Yasuo Ikeda, T. Kokubo, 1999, British journal of haematology.

Molecular characterization of L-amino acid oxidase from Agkistrodon halys blomhoffii with special reference to platelet aggregation.

K. Titani, T. Kokubo, A. Yoshioka, 2001, Biochimica et biophysica acta.

Increase of coagulation potential in chronic spontaneous urticaria

M. Shima, M. Hide, A. Yoshioka, 2011, Allergy.

Enhancement of Tissue Factor Expression in Monocyte-Derived Dendritic Cells by Pentraxin 3 and Its Modulation by C1 Esterase Inhibitor

Y. Sakurai, K. Tatsumi, S. Kasuda, 2019, International Archives of Allergy and Immunology.

The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay

A. Giles, M. Shima, A. Yoshioka, 2006, Journal of thrombosis and haemostasis : JTH.

Acute appendicitis in a 14-year-old boy with familial Mediterranean fever

Y. Sakurai, T. Murata, Hirohisa Hirata, 2015 .

Alterations of T cell receptor Vbeta repertoire of CD8 T lymphocytes in immune tolerance induction in two hemophilia A patients with inhibitors.

M. Shima, A. Yoshioka, T. Yoshioka, 2011, Vojnosanitetski pregled.

Autoimmune Aspects of Kawasaki Disease.

Y. Sakurai, Yoshihiko Sakurai, 2019, Journal of investigational allergology & clinical immunology.

Increased thrombin generation potential in patients with chronic spontaneous urticaria.

M. Shima, M. Hide, Y. Sakurai, 2015, Allergology international : official journal of the Japanese Society of Allergology.

Early-Stage Juvenile Fibromyalgia in a 12-Year-Old Girl

Y. Sakurai, 2015 .

Juvenile polymyositis associated with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody in a 13-year-old girl

T. Mimori, I. Tanaka, Y. Sakurai, 2017, Modern rheumatology.

Persistent Endothelial Damage after Intravenous Immunoglobulin Therapy in Kawasaki Disease

Y. Sakurai, H. Takatsuka, M. Nishino, 2014, International Archives of Allergy and Immunology.

Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery

Y. Hayata, Tomoko Matsumoto, M. Shima, 2011, Paediatric anaesthesia.

A critical role for thrombin in platelet aggregation under high shear stress.

K. Nogami, M. Shima, A. Yoshioka, 2004, Thrombosis research.

Superficial Fibromatosis Mimicking Subcutaneous Hematoma: An Unusual and Difficult Diagnosis in a Patient with Mild Hemophilia A

H. Sugimoto, A. Nonomura, M. Shima, 2007, International journal of hematology.

Changes in BAFF/APRIL levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy.

Y. Sakurai, T. Takeda, S. Yoshida, 2013, Journal of investigational allergology & clinical immunology.

Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.

A. Kang, Y. Sakurai, J. Stuart, 2002, Arthritis and rheumatism.

Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro.

M. Shima, A. Yoshioka, Y. Sakurai, 2006, Alcoholism, clinical and experimental research.

Oropharyngeal symptoms without systemic reactions as a risk factor for food allergen intolerance: a longitudinal pediatric study

K. Saeki, Y. Sakurai, M. Hamada, 2022, Allergy, Asthma & Clinical Immunology.

An Analog Peptide that Suppresses Collagen‐Induced Arthritis

A. Kang, Y. Sakurai, J. Stuart, 2004, The American journal of the medical sciences.

Inhibition of human platelet aggregation by L-amino acid oxidase purified from Naja naja kaouthia venom.

K. Titani, A. Yoshioka, Y. Fujimura, 2001, Toxicon : official journal of the International Society on Toxinology.

Sequential Gene Expression Analysis of Coagulation Factors and Proteaseactivated Receptors in Hematopoietic Lineage Development

M. Shima, Y. Sakurai, K. Tatsumi, 2014 .

Heparin-induced inhibitory effects of a prothrombin complex concentrate on global tests of haemostasis

Tomoko Matsumoto, K. Nogami, M. Shima, 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Recurrence of Idiopathic Pulmonary Hemosiderosis Associated with Rising Plasma IgE Levels and Antibody Titers to Specific Inhalants during a 10-Year Follow-Up

A. Yoshioka, Y. Sakurai, M. Shibata, 2005 .

Acute ethanol intoxication suppresses pentraxin 3 expression in a mouse sepsis model involving cecal ligation and puncture.

Y. Sakurai, S. Kasuda, R. Kudo, 2017, Alcohol.

Vitamin D deficiency rickets due to fish-restricted diet without abnormality in the lower extremity X-ray

Y. Sakurai, H. Takatsuka, T. Tsukuda, 2012 .

Therapeutic approaches for treating hemophilia A using embryonic stem cells.

M. Shima, Y. Sakurai, K. Tatsumi, 2016, Hematology/oncology and stem cell therapy.

Acquired Hemophilia A: A Frequently Overlooked Autoimmune Hemorrhagic Disorder

Y. Sakurai, Tomohiro Takeda, 2014, Journal of immunology research.

Persistent Idiopathic Facial Pain Associated with Somatoform Disorder in an 11-Year-Old Boy

Y. Sakurai, Asami Fujii, Fumie Kato, 2019, Case reports in psychiatry.

Early-Onset Chronic Inflammatory Disease Associated with Maternal Microchimerism

Hiroshi Suzuki, Y. Sakurai, Tomohiro Takeda, 2012, Case reports in pediatrics.

Induced Pluripotent Stem Cell-Derived Hematopoietic Embryoid Bodies Improve Mouse Status in Septic Peritonitis

Y. Sakurai, S. Kasuda, R. Kudo, 2019, Bulletin of Experimental Biology and Medicine.

Arthroscopic synovectomies combined with reduced weight‐bearing using patella tendon‐bearing braces were very effective for progressed haemophilic ankle arthropathy in three paediatric patients

Y. Takakura, M. Shima, A. Yoshioka, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life‐threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor

M. Shima, A. Yoshioka, J. Giddings, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Elevation of B cell-activating factor belonging to the tumour necrosis factor [corrected] family (BAFF) in haemophilia A patients with inhibitor.

M. Shima, A. Yoshioka, Y. Sakurai, 2009, Thrombosis and Haemostasis.

A multi-center survey of hospital charges for hemophilia and the related diseases in Japan

K. Amano, M. Shima, S. Higasa, 2006 .

Establishment of embryonic stem cells secreting human factor VIII for cell‐based treatment of hemophilia A

K. Ohashi, S. Pipe, M. Shima, 2008, Journal of thrombosis and haemostasis : JTH.

Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors.

M. Shima, A. Yoshioka, I. Tanaka, 2004, Haematologica.

Higher recovery of factor VIII (FVIII) with intermediate FVIII/von Willebrand factor concentrate than with recombinant FVIII in a haemophilia A patient with an inhibitor

Tomoko Matsumoto, M. Shima, A. Yoshioka, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

Development of Acquired Factor V Inhibitor After Surgical Procedure Without the Use of Fibrin Tissue Adhesives: A Case Report

Y. Sakurai, Tomohiro Takeda, Hirohisa Hirata, 2021, Cureus.

Highly Conserved Antigenic Structure of the Factor VIII C2 Domain in Some Mammals

Tomoko Matsumoto, M. Shima, A. Yoshioka, 2005, International journal of hematology.

Effectiveness of factor VIII infusions in haemophilia A patients with high responding inhibitors

A. Giles, M. Shima, A. Yoshioka, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Identification of the Binding Site for an Alloantibody to von Willebrand Factor which Inhibits Binding to Glycoprotein Ib within the Amino-terminal Region Flanking the A1 Domain

A. Nomura, M. Shima, A. Yoshioka, 1999, Thrombosis and Haemostasis.

Successful use of recombinant factor VIII devoid of von Willebrand factor during multiple teeth extractions in a patient with type 3 von Willebrand disease.

M. Shima, A. Yoshioka, T. Kirita, 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Human Factor VIII Inhibitor Alloantibodies with a C2 Epitope Inhibit Factor Xa-catalyzed Factor VIII Activation: A new Anti-factor VIII Inhibitory Mechanism

K. Nogami, M. Shima, A. Yoshioka, 2002, Thrombosis and Haemostasis.

Replacement therapy with plasma-derived factor VIII concentrates induces skew in T-cell receptor usage and clonal expansion of CD8+ T-cell in HIV-seronegative hemophilia patients

Y. Tsuruta, R. Suzuki, M. Shima, 2003, Thrombosis and Haemostasis.

Successful management of Mallory‐Weiss syndrome in a haemophilia A patient with inhibitor by recombinant activated factor VII

M. Shima, A. Yoshioka, I. Tanaka, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C-catalyzed inactivation.

Hiroshi Suzuki, K. Nogami, M. Shima, 2002, Blood.

Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease.

Y. Sakurai, T. Takeda, J. Kato, 2010, Journal of investigational allergology & clinical immunology.

von Willebrand factor in cadaveric urine for forensic investigation.

M. Shima, Y. Sakurai, K. Tatsumi, 2009, Legal medicine.

Factor VIII-Mediated Global Hemostasis in the Absence of von Willebrand Factor

M. Shima, A. Yoshioka, M. Takeyama, 2007, International journal of hematology.

Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome.

A. Utani, H. Tsutsumi, T. Nakahata, 2004, Blood.

The cDNA cloning of human placental ecto‐ATP diphosphohydrolases I and II 1

K. Titani, T. Kokubo, M. Matsumoto, 1999, FEBS letters.

Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice

A. Kang, D. Brand, Y. Sakurai, 2006, Arthritis research & therapy.

Induced Pluripotent Stem Cell-Derived Hematopoietic Embryoid Bodies Secrete Sphingosine-1-Phosphate and Revert Endothelial Injury

Y. Sakurai, S. Kasuda, R. Kudo, 2018, Bulletin of Experimental Biology and Medicine.

Inhibition assay for the binding of biotinylated von Willebrand factor to platelet-bound microtiter wells in the presence of ristocetin or botrocetin.

A. Yoshioka, Y. Fujimura, Y. Sakurai, 1996, Analytical biochemistry.

The cDNA Cloning and Molecular Characterization of a Snake Venom Platelet Glycoprotein Ib-binding Protein, Mamushigin, from Agkistrodon halys blomhoffii Venom

K. Titani, K. Imamura, Masami Suzuki, 1998, Thrombosis and Haemostasis.

Complete Amino Acid Sequence and Identification of the Platelet Glycoprotein Ib-binding Site of Jararaca GPIb-BP, a Snake Venom Protein Isolated from Bothrops jararaca(*)

K. Titani, K. Hirano, Masami Suzuki, 1996, The Journal of Biological Chemistry.

Primary structure of alboaggregin-B purified from the venom of Trimeresurus albolabris.

K. Titani, Y. Fujimura, M. Suzuki, 1996, Biochemical and biophysical research communications.

Purification and amino acid sequence of halystase from snake venom of Agkistrodon halys blomhoffii, a serine protease that cleaves specifically fibrinogen and kininogen.

K. Titani, Y. Yamamoto, Y. Fujimura, 1998, European journal of biochemistry.

Complete amino acid sequence of kaouthiagin, a novel cobra venom metalloproteinase with two disintegrin-like sequences.

K. Titani, M. Ito, Masami Suzuki, 2001, Biochemistry.

Factitious Purpura in a 10‐Year‐Old Girl

S. Miyagawa, A. Yoshioka, Y. Sakurai, 2009, Pediatric dermatology.

Induced Pluripotent Stem Cell-Derived Hematopoietic Embryoid Bodies Improve Mouse Status in Septic Peritonitis

Y. Sakurai, S. Kasuda, R. Kudo, 2019, Bulletin of Experimental Biology and Medicine.

Anaphylaxis to Polyvinylpyrrolidone in Povidone-Iodine for Impetigo Contagiosum in a Boy with Atopic Dermatitis

A. Yoshioka, Y. Sakurai, Tomohiro Takeda, 2008, International Archives of Allergy and Immunology.

Transient Macroamylasemia in a Severely Multiple-Handicapped Child Following the Development of Acute Bronchitis

Y. Sakurai, 2015 .

Anticoagulant activity of M-LAO, L-amino acid oxidase purified from Agkistrodon halys blomhoffii, through selective inhibition of factor IX.

Katsumi Nishiya, Tomoko Matsumoto, M. Shima, 2003, Biochimica et biophysica acta.

Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation

O. Ohara, I. Kobayashi, T. Makino, 2020, Annals of the Rheumatic Diseases.

Low-Dosage Intravenous Immunoglobulin in the Management of a Patient with Acquired von Willebrand Syndrome Associated with Monoclonal Gammopathy of Undetermined Significance

M. Matsumoto, Y. Fujimura, T. Hayashi, 2002, Pathophysiology of Haemostasis and Thrombosis.

Derivation of leukemic plasmacytoid dendritic cells coexpressing a progenitor cell surface antigen, CD117, without interferon-alpha production.

N. Kadowaki, Y. Sakurai, Tomohiro Takeda, 2007, Asian Pacific journal of allergy and immunology.

Placental ecto-ATP diphosphohydrolase: its structural feature distinct from CD39, localization and inhibition on shear-induced platelet aggregation.

K. Titani, Yasuo Ikeda, N. Narita, 1998, International journal of hematology.

Brief Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor- (cid:1) B activation: common genetic etiology with Blau syndrome

A. Utani, H. Tsutsumi, T. Nakahata, 2005 .

Adenovirus-Mediated Transfer of Human Placental Ectonucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation In Vitro and Arterial Thrombus Formation In Vivo

S. Tamura, K. Hatakeyama, Y. Asada, 2005, Circulation.

Regulation of coagulation factors during liver regeneration in mice: mechanism of factor VIII elevation in plasma.

Kohei Tatsumi, Teruo Okano, T. Okano, 2011, Thrombosis research.

catalyzed inactivation - activated protein C A novel mechanism of factor VIII protection by von Willebrand factor from

Hiroshi Suzuki, K. Nogami, M. Shima, 2013 .

Ecthyma Gangrenosum‐like Lesions in a Healthy Child after Infection Treated with Antibiotics

S. Miyagawa, A. Yoshioka, Y. Sakurai, 2005, Pediatric dermatology.

Preschool sarcoidosis mimicking juvenile rheumatoid arthritis: The significance of gallium scintigraphy and skin biopsy in the differential diagnosis

S. Miyagawa, S. Kamisue, Y. Sakurai, 1997, Acta paediatrica Japonica : Overseas edition.

Expression of coagulation factors from murine induced pluripotent stem cell-derived liver cells

T. Okano, K. Ohashi, M. Shima, 2011, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Repression of Factor VIII Inhibitor Development with Apoptotic Factor VIII-expressing Embryonic Stem Cells

M. Shima, Y. Sakurai, K. Tatsumi, 2013, Hematology Reports.

Enhanced low shear stress induced platelet aggregation by Shiga‐like toxin 1 purified from Escherichia coli O157

K. Titani, E. Kita, Y. Ikeda, 2001, American journal of hematology.

Efficacy of the H2-receptor antagonist famotidine on chronic spontaneous urticaria in children

Y. Sakurai, H. Takatsuka, M. Nishino, 2013 .

Elevation of B cell-activating factor belonging to the tumour necrosis family family (BAFF) in haemophilia A patients with inhibitor

M. Shima, A. Yoshioka, Y. Sakurai, 2009, Thrombosis and Haemostasis.

Selective factor VIII and V inactivation by iminodiacetate ion exchange resin through metal ion adsorption *

Tomoko Matsumoto, K. Nogami, M. Shima, 2008, British journal of haematology.

Factor V C2 domain contains a major thrombin‐binding site responsible for thrombin‐catalyzed factor V activation

K. Nogami, M. Shima, A. Yoshioka, 2006, Journal of thrombosis and haemostasis : JTH.

von Willebrand Factor Protects Ca2+-Dependent Structure of the Factor VIII Light Chain.

K. Nogami, M. Shima, A. Yoshioka, 2005 .

Molecular characterization of an arthritogenic collagen peptide interacting with I‐Ar

Y. Sakurai, J. Stuart, E. Rosloniec, 2006, Immunology.

Blood-Circulating Type 2 Follicular Helper T Cells in Pediatric Allergy Patients

Y. Sakurai, M. Hamada, Tomohiro Takeda, 2020 .

Experimental hypercoagulable state induced by tissue factor expression in monocyte-derived dendritic cells and its modulation by C1 inhibitor

Y. Sakurai, K. Tatsumi, S. Kasuda, 2018, Journal of Thrombosis and Thrombolysis.